Vitamin D deficiency is widespread among women with breast cancer. Guidelines currently recommend daily supplementation with 400 IU vitamin D3; however, attainment of a circulating level of 25-hydroxyvitamin D defined as sufficient (that is, ≥75 nmol/l) might not be possible with this level of supplementation, according to data published in the Journal of Clinical Oncology.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride 250–287 (National Academy Press, Washington, DC, 1997).
Crew, K. D. et al. High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J. Clin. Oncol. 27, 2151–2156 (2009).
Vieth, R., Chan, P. C. & MacFarlane, G. D. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am. J. Clin. Nutr. 73, 288–294 (2001).
Hollis, B. W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 135, 317–322 (2005).
Talwar, S. A., Aloia, J. F., Pollack, S. & Yeh, J. K. Dose response to vitamin D supplementation among postmenopausal African American women. Am. J. Clin. Nutr. 86, 1657–1662 (2007).
Heaney, R. P., Davies, K. M., Chen, T. C., Holick, M. F. & Barger-Lux, M. J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 77, 204–210 (2003).
Wactawski-Wende, J. et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 354, 684–696 (2006).
Giovannucci, E. et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J. Natl Cancer Inst. 98, 451–459 (2006).
Abbas, S. et al. Serum 25-hydroxyvitamin D and risk of postmenopausal breast cancer—results of a large case–control study. Carcinogenesis 29, 93–99 (2008).
Lappe, J. M., Travers-Gustafson, D., Davies, K. M., Recker, R. R. & Heaney, R. P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 85, 1586–1591 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Bruce W. Hollis is a consultant for DiaSorin.
Rights and permissions
About this article
Cite this article
Hollis, B. US recommendations fail to correct vitamin D deficiency. Nat Rev Endocrinol 5, 534–536 (2009). https://doi.org/10.1038/nrendo.2009.178
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2009.178